These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29781740)

  • 1. Predicting the impact of pneumococcal conjugate vaccine programme options in Vietnam.
    Le Polain De Waroux O; Edmunds WJ; Takahashi K; Ariyoshi K; Mulholland EK; Goldblatt D; Choi YH; Anh DD; Yoshida LM; Flasche S
    Hum Vaccin Immunother; 2018; 14(8):1939-1947. PubMed ID: 29781740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.
    Ojal J; Flasche S; Hammitt LL; Akech D; Kiti MC; Kamau T; Adetifa I; Nurhonen M; Scott JAG; Auranen K
    Vaccine; 2017 Aug; 35(35 Pt B):4561-4568. PubMed ID: 28729018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.
    Satzke C; Dunne EM; Choummanivong M; Ortika BD; Neal EFG; Pell CL; Nation ML; Fox KK; Nguyen CD; Gould KA; Hinds J; Chanthongthip A; Xeuatvongsa A; Mulholland EK; Sychareun V; Russell FM
    Vaccine; 2019 Jan; 37(2):296-305. PubMed ID: 30502068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
    van Hoek AJ; Sheppard CL; Andrews NJ; Waight PA; Slack MP; Harrison TG; Ladhani SN; Miller E
    Vaccine; 2014 Jul; 32(34):4349-55. PubMed ID: 24657717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya.
    Flasche S; Ojal J; Le Polain de Waroux O; Otiende M; O'Brien KL; Kiti M; Nokes DJ; Edmunds WJ; Scott JAG
    BMC Med; 2017 Jun; 15(1):113. PubMed ID: 28592303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR).
    Abu Seir R; Azmi K; Hamdan A; Namouz H; Jaar F; Jaber H; Rubin C; Doron D; Rahav G; Abdeen Z; Regev-Yochay G
    PLoS One; 2018; 13(11):e0206927. PubMed ID: 30418989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia.
    Roca A; Bojang A; Bottomley C; Gladstone RA; Adetifa JU; Egere U; Burr S; Antonio M; Bentley S; Kampmann B;
    Vaccine; 2015 Dec; 33(51):7144-7151. PubMed ID: 26592141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage.
    Tin Tin Htar M; Sings HL; Syrochkina M; Taysi B; Hilton B; Schmitt HJ; Gessner BD; Jodar L
    Expert Rev Vaccines; 2019 Dec; 18(12):1243-1270. PubMed ID: 31587592
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimating pneumococcal carriage dynamics in adults living with HIV in a mature infant pneumococcal conjugate vaccine programme in Malawi, a modelling study.
    Phiri J; Sibale L; Mlongoti L; Mitole N; Kusakala A; Khwiya M; Kayembe T; Lisimba E; Kapwata P; Malisita K; Chaguza C; Ferreira DM; Thindwa D; Jambo K
    BMC Med; 2024 Sep; 22(1):419. PubMed ID: 39334289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.
    Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL
    Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.
    Wouters I; Van Heirstraeten L; Desmet S; Blaizot S; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
    Vaccine; 2018 Jan; 36(1):15-22. PubMed ID: 29180027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent prevalence of nasopharyngeal carriage of streptococcus pneumoniae before conjugate vaccine introduction: a prediction model based on a meta-analysis.
    Le Polain de Waroux O; Flasche S; Prieto-Merino D; Edmunds WJ
    PLoS One; 2014; 9(1):e86136. PubMed ID: 24465920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
    Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
    Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.
    Melegaro A; Choi YH; George R; Edmunds WJ; Miller E; Gay NJ
    BMC Infect Dis; 2010 Apr; 10():90. PubMed ID: 20377886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
    Sigaúque B; Moiane B; Massora S; Pimenta F; Verani JR; Mucavele H; Chaúque A; Quintó L; Dos Santos RT; Carvalho MDG; Whitney CG; Lessa FC
    Pediatr Infect Dis J; 2018 Oct; 37(10):1054-1060. PubMed ID: 30216295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and molecular characterization of Streptococcus pneumoniae carriage strains in pre-school children in Arkhangelsk, northern European Russia, prior to the introduction of conjugate pneumococcal vaccines.
    Vorobieva S Jensen V; Furberg AS; Slotved HC; Bazhukova T; Haldorsen B; Caugant DA; Sundsfjord A; Valentiner-Branth P; Simonsen GS
    BMC Infect Dis; 2020 Apr; 20(1):279. PubMed ID: 32293324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil.
    Brandileone MC; Zanella RC; Almeida SCG; Brandao AP; Ribeiro AF; Carvalhanas TMP; Sato H; Andrade AL; Verani JR;
    Vaccine; 2016 Nov; 34(46):5604-5611. PubMed ID: 27692770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction.
    Njuma Libwea J; Gröndahl-Yli-Hannuksela K; Kobela M; Toropainen M; Nyholm O; Ndombo PK; Koulla-Shiro S; Nohynek H; Nuorti JP; Vuopio J; Palmu AA
    Int J Infect Dis; 2020 Sep; 98():113-120. PubMed ID: 32562849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.